Thomas Calder

Structural and regulatory mutations in Vibrio parahaemolyticus type III secretion systems display variable effects on virulence.

K. Orth, A. Krachler, D. Salomon, 2014, FEMS microbiology letters.

Leveraging lessons learned from the COVID-19 pandemic for HIV

Jerome H. Kim, R. Koup, M. McElrath, 2022, Communications Medicine.

Vibrio Type III Effector VPA1380 Is Related to the Cysteine Protease Domain of Large Bacterial Toxins

N. Grishin, L. Kinch, K. Orth, 2014, PloS one.

Vibrio parahaemolyticus cell biology and pathogenicity determinants.

K. Orth, Christopher A. Broberg, Thomas Calder, 2011, Microbes and infection.

Mind the gap from research laboratory to clinic: Challenges and opportunities for next-generation assays in human diseases

D. O’Connor, S. Kleinstein, G. Tomaras, 2021, Vaccine.